Volume | 78,519 |
|
|||||
News | - | ||||||
Day High | 16.53 | Low High |
|||||
Day Low | 16.04 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
CryoPort Inc | CYRX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
16.16 | 16.04 | 16.53 | 16.03 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
2,608 | 78,519 | $ 16.37 | $ 1,285,110 | - | 9.00 - 24.17 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
14:58:23 | 10 | $ 16.54 | USD |
CryoPort Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
803.23M | 48.98M | - | 233.26M | -107.59M | -2.20 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
CryoPort News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYRX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 16.39 | 16.84 | 15.19 | 16.11 | 410,808 | 0.14 | 0.85% |
1 Month | 17.75 | 20.105 | 15.19 | 17.36 | 396,869 | -1.22 | -6.87% |
3 Months | 14.92 | 20.105 | 13.93 | 16.58 | 453,680 | 1.61 | 10.79% |
6 Months | 10.19 | 20.105 | 9.00 | 14.52 | 519,902 | 6.34 | 62.22% |
1 Year | 20.60 | 24.17 | 9.00 | 15.19 | 565,768 | -4.07 | -19.76% |
3 Years | 55.32 | 86.30 | 9.00 | 28.89 | 479,725 | -38.79 | -70.12% |
5 Years | 13.68 | 86.30 | 9.00 | 31.65 | 519,766 | 2.85 | 20.83% |
CryoPort Description
CryoPort Inc is a provider of a temperature-controlled supply chain for the life sciences industry by providing an evolving platform of critical products and solutions including advanced packaging, informatics, specialty logistics services, biostorage services, and cryogenic life sciences equipment. The company provides global solutions to the biopharma/pharma, animal health, and human reproductive medicine markets. Its primary focus is on addressing the critical temperature-controlled supply chain needs within the biopharmaceutical space with an emphasis on serving the rapidly growing cell and gene therapy market. |